Fastigium
Fastigium biotechnology will consist of improving the in vivo transfection of mRNA by optimizing the endocytosis of LNPs and the escape of mRNA from endosomes.
News
OST Group becomes a shareholder in July 2019
July 08, 2019
©copyright 2016 Coqpit